Literature DB >> 35196139

Evaluating Vitamin D Status in Infants Less than Seven Months; What Are the Preferred Biochemical Measurements?

Grace G Pouch1, Myla Ebeling2, Judy R Shary2, Bruce W Hollis2, Cynthia R Howard3, Carol L Wagner2.   

Abstract

Background: To ensure the safety of higher dose vitamin D supplementation in pregnant and lactating mothers, and urinary calcium/creatinine (UCa/Cr) ratios, serum calcium, and serum 25(OH)D concentrations are closely monitored. To achieve optimal maternal and infant vitamin D status, while avoiding hypercalcemia, safety measures assessing vitD supplementation must be reliable. Whether or not this holds true for infants before 7 months of age, remains unknown. Objective: Analyze the association among UCa/Cr ratio, serum calcium, intact serum parathyroid hormone (iPTH), 25(OH)D, and 25(OH)D/iPTH ratio in infants to determine whether evidence supports the use of these parameters as valuable measures of hypervitaminosis D or toxicity in infants.
Methods: A series of analyses were performed on the cohort of infants who participated in the National Institute of Child Health and Human Development lactation vitD supplementation trial to determine the association among UCa/Cr ratio, serum calcium, iPTH, 25(OH)D, and 25(OH)D/iPTH ratio.
Results: Upon multivariate analysis, serum calcium was significantly associated with 25(OH)D (p = 0.0441), iPTH (p = 0.0017), and 25(OH)D/iPTH ratio (p = 0.0001). Infant UCa/Cr did not associate with 25(OH)D but did associate with iPTH (p = 0.0008) and 25(OH)D/iPTH ratio (p = 0.0001). The correlation between UCa/Cr and 25(OH)D/iPTH ratios was significantly stronger than the association between UCa/Cr ratio and iPTH. Serum calcium more strongly correlated with 25(OH)D/iPTH ratio versus 25(OH)D and iPTH.
Conclusion: In this healthy cohort of infants 1 to 7 months old, UCa/Cr and serum calcium are more valid indicators of 25(OH)D/iPTH ratio than either 25(OH)D or iPTH alone. Moreover, serum calcium (and not UCa/Cr) is a valid indicator of infant total circulating 25(OH)D and should be measured if vitamin D toxicity is a concern. Clinical Trial Registration number: FDA IND Number: 66,346; ClinicalTrials.gov Number: NCT00412074.

Entities:  

Keywords:  25(OH)D/iPTH ratio; 25-hydroxyvitamin D; infant; safety measures; urinary calcium/creatinine ratio; vitamin D supplementation

Mesh:

Substances:

Year:  2022        PMID: 35196139      PMCID: PMC9271327          DOI: 10.1089/bfm.2021.0237

Source DB:  PubMed          Journal:  Breastfeed Med        ISSN: 1556-8253            Impact factor:   2.335


  29 in total

1.  What's new in mother-infant vitamin D deficiency: a 21st century perspective.

Authors:  Adekunle Dawodu
Journal:  Med Princ Pract       Date:  2011-10-20       Impact factor: 1.927

Review 2.  Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D.

Authors:  Bruce W Hollis
Journal:  J Nutr       Date:  2005-02       Impact factor: 4.798

3.  The impact of vitamin D supplementation on vitamin D level, urinary calcium excretion and bone density in patients with hypercalciuria and vitamin D deficiency - preliminary report.

Authors:  Joanna Milart; Katarzyna Jobs; Małgorzata Tłustochowicz; Milena Pogonowska; Bolesław Kalicki
Journal:  Dev Period Med       Date:  2018

Review 4.  The role of vitamin D in pregnancy and lactation: emerging concepts.

Authors:  Carol L Wagner; Sarah N Taylor; Donna D Johnson; Bruce W Hollis
Journal:  Womens Health (Lond)       Date:  2012-05

5.  Association of urinary calcium excretion with serum calcium and vitamin D levels.

Authors:  Anita Rathod; Olivier Bonny; Idris Guessous; Paolo M Suter; David Conen; Paul Erne; Isabelle Binet; Luca Gabutti; Augusto Gallino; Franco Muggli; Daniel Hayoz; Antoinette Péchère-Bertschi; Fred Paccaud; Michel Burnier; Murielle Bochud
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-17       Impact factor: 8.237

Review 6.  Assessment of dietary vitamin D requirements during pregnancy and lactation.

Authors:  Bruce W Hollis; Carol L Wagner
Journal:  Am J Clin Nutr       Date:  2004-05       Impact factor: 7.045

7.  Safety Aspects of a Randomized Clinical Trial of Maternal and Infant Vitamin D Supplementation by Feeding Type Through 7 Months Postpartum.

Authors:  Carol L Wagner; Thomas C Hulsey; Myla Ebeling; Judy R Shary; Golaleh Asghari; Cynthia R Howard; John E Baatz; Danforth A Newton; Amy E Wahlquist; Susan G Reed; Sarah N Taylor; Ruth A Lawrence; Bruce W Hollis
Journal:  Breastfeed Med       Date:  2020-09-11       Impact factor: 1.817

8.  Urinary excretion of calcium and phosphate in preterm infants.

Authors:  Narendra Aladangady; Pietro G Coen; Madeleine P White; Margaret D Rae; T James Beattie
Journal:  Pediatr Nephrol       Date:  2004-11       Impact factor: 3.714

9.  Maternal Versus Infant Vitamin D Supplementation During Lactation: A Randomized Controlled Trial.

Authors:  Bruce W Hollis; Carol L Wagner; Cynthia R Howard; Myla Ebeling; Judy R Shary; Pamela G Smith; Sarah N Taylor; Kristen Morella; Ruth A Lawrence; Thomas C Hulsey
Journal:  Pediatrics       Date:  2015-10       Impact factor: 7.124

10.  Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer.

Authors:  B W Hollis; J Q Kamerud; S R Selvaag; J D Lorenz; J L Napoli
Journal:  Clin Chem       Date:  1993-03       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.